Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease

Donato Rigante; Clelia Cipolla; Aurora Natalia Rossodivita

doi:10.1297/cpe.27.101

Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease

Donato Rigante^*
, Clelia Cipolla
, Aurora Natalia Rossodivita

^*Corresponding author

Research output: Contribution to journal › Article

3 Citations (Scopus)

Abstract

This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.

Original language	English
Pages (from-to)	101-105
Number of pages	5
Journal	Clinical Pediatric Endocrinology
Volume	2018
DOIs	https://doi.org/10.1297/cpe.27.101
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Growth Hormone

Access to Document

10.1297/cpe.27.101

Cite this

@article{ba02740cd2ae4e36ba0fdf0e1a430e29,

title = "Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease",

abstract = "This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.",

keywords = "Growth Hormone, Growth Hormone",

author = "Donato Rigante and Clelia Cipolla and Rossodivita, \{Aurora Natalia\}",

year = "2018",

doi = "10.1297/cpe.27.101",

language = "English",

volume = "2018",

pages = "101--105",

journal = "Clinical Pediatric Endocrinology",

issn = "0918-5739",

publisher = "Jeff Corporation Co. Ltd",

}

TY - JOUR

T1 - Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease

AU - Rigante, Donato

AU - Cipolla, Clelia

AU - Rossodivita, Aurora Natalia

PY - 2018

Y1 - 2018

N2 - This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.

AB - This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.

KW - Growth Hormone

UR - http://hdl.handle.net/10807/118955

U2 - 10.1297/cpe.27.101

DO - 10.1297/cpe.27.101

M3 - Article

SN - 0918-5739

VL - 2018

SP - 101

EP - 105

JO - Clinical Pediatric Endocrinology

JF - Clinical Pediatric Endocrinology

ER -

Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this